Neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury: long-term urodynamic findings

Autor: Schöps TF Schneider MP Steffen F Ineichen BV Mehnert U Kessler TM.

Publikováno v: BJU Int

OBJECTIVES: To investigate long term urodynamic findings in patients with spinal cord injury (SCI) with neurogenic lower urinary tract dysfunction (NLUTD). PATIENTS AND METHODS: A consecutive series of 246 patients with SCI (=5 years since injury) an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=snsf_p3_pubs::26f8d5c9dd73209984ef9a7424f5721e

Retinal Function in Advanced Multiple Sclerosis.

Autor: Hanson JVM; Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Single S; Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Eberle RB; Masters Program in Biostatistics, University of Zurich, Zurich, Switzerland., Kana V; Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Ineichen BV; Institute for Epidemiology, Biostatistics, and Prevention, Department of Biostatistics, University of Zurich, Zurich, Switzerland.; Clinical Neuroscience Center, University of Zurich, Zurich, Switzerland., Gerth-Kahlert C; Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Publikováno v: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2024 Nov 04; Vol. 65 (13), pp. 2.

Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysis.

Autor: Hagbohm C; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden., Ouellette R; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden., Flanagan EP; Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Jonsson DI; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Department of Neurophysiology, Karolinska University Hospital, Stockholm, Sweden., Piehl F; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Centre for Neurology, Academic Specialist Centre, Karolinska University Hospital, Stockholm, Sweden., Banwell B; Division of Child Neurology, Children's Hospital of Philadelphia, Department of Neurology and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Wickström R; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Iacobaeus E; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden., Granberg T; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden., Ineichen BV; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Center for Reproducible Science, University of Zürich, Zürich, Switzerland.

Publikováno v: European journal of neurology [Eur J Neurol] 2024 Jul; Vol. 31 (7), pp. e16284. Date of Electronic Publication: 2024 Mar 20.

Natural language processing analysis of the theories of people with multiple sclerosis about causes of their disease.

Autor: Haag C; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.; Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland., Steinemann N; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland., Ajdacic-Gross V; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland., Schlomberg JTT; Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland.; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Ineichen BV; Center for Reproducible Science, University of Zurich, Zurich, Switzerland.; Clinical Neuroscience Center, University of Zurich, Zurich, Switzerland., Stanikić M; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.; Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland., Dressel H; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.; Division of Occupational and Environmental Medicine, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Daniore P; Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland.; Digital Society Initiative, University of Zurich, Zurich, Switzerland., Roth P; Department of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., Ammann S; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland., Calabrese P; Division of Molecular and Cognitive Neuroscience, Neuropsychology and Behavioral Neurology Unit, University of Basel, Basel, Switzerland., Kamm CP; Neurocentre, Lucerne Cantonal Hospital, Lucerne, Switzerland.; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Kesselring J; Department of Neurology and Neurorehabilitation, Rehabilitation Center Valens, Valens, Switzerland., Kuhle J; Department of Neurology, University Hospital Basel and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel, Departments of Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland., Zecca C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Puhan MA; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland., von Wyl V; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. viktor.vonwyl@uzh.ch.; Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland. viktor.vonwyl@uzh.ch.; Digital Society Initiative, University of Zurich, Zurich, Switzerland. viktor.vonwyl@uzh.ch.

Publikováno v: Communications medicine [Commun Med (Lond)] 2024 Jun 24; Vol. 4 (1), pp. 122. Date of Electronic Publication: 2024 Jun 24.

Myelin bilayer mapping in the human brain in vivo.

Autor: Baadsvik EL; Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland., Weiger M; Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland., Froidevaux R; Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland., Schildknecht CM; Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland., Ineichen BV; Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Center for Reproducible Science, University of Zurich, Zurich, Switzerland., Pruessmann KP; Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.

Publikováno v: Magnetic resonance in medicine [Magn Reson Med] 2024 Jun; Vol. 91 (6), pp. 2332-2344. Date of Electronic Publication: 2024 Jan 03.